Diabetes decisions — 2022

The Board has remanded the case due to a duty to assist error, and now requires the Director, Compensation Service, to consider whether a TDIU should be granted on an extraschedular basis prior to May 30, 2019.

The Veteran's claims for service connection for non-Hodgkin's lymphoma, diabetes mellitus type II, and hypertension have been granted. The case is remanded to correct a pre-decisional duty to assist error regarding the Veteran's exposure to contaminated groundwater, environmental and chemical toxins, asbestos, and lead.

The Veteran withdrew their appeals for service connection for various conditions, including PTSD, coronary artery disease, diabetes mellitus type 2, Parkinsonism, and essential tremors. The Board has dismissed these appeals.

The Veteran's claims for service connection for diabetes, bilateral upper and lower extremity peripheral neuropathies are denied as there is no evidence of exposure to herbicide agents/Agent Orange in Vietnam or on the USS Ranger. The claimed disabilities were not shown to be related to service.

The Veteran's claim for SMC based on the need for aid and attendance is remanded due to a duty to assist error. A VA medical opinion is needed to distinguish between service-connected and non-service-connected disabilities.

The Board has denied the Veteran's claims for service connection for a lower back disability, left and right lower extremity radiculopathy, and high sugar or diabetes mellitus. The evidence does not support a finding that these conditions are related to service.,There is no credible evidence of a current diagnosis of arthritis of the low back within one year of discharge from active duty, nor any evidence of continuity of symptoms since service.

The Veteran's ischemic heart disease and diabetes mellitus, type II are granted as service connected due to herbicide exposure during his active duty in Vietnam.

The Veteran's prostate cancer, diabetes mellitus, and hypertension were denied as not service-connected.,Service connection was denied for all three conditions due to a lack of evidence linking them to the Veteran's military service.

The appeal of high cholesterol is dismissed. The appeals for coronary artery disease, diabetes mellitus type II and hypertension are remanded.

The Veteran's diabetes mellitus, type 2 (DM II) was caused by the VA-prescribed prednisone for his sarcoidosis. The Board found that this event was not reasonably foreseeable and granted compensation under 38 U.S.C. § 1151.

The Board has denied service connection for bilateral hearing loss and diabetes mellitus type II as there is no evidence of these conditions during or within one year after the Veteran's military service, and they are not otherwise related to his service.

The Veteran's total combined disability rating remains at 60 percent after the grant of a 10 percent evaluation for hypertension, as his other service-connected conditions do not warrant an increase in the overall rating.

The Board denied the Veteran's claim for compensation under 38 U.S.C. § 1151 due to a claimed infection and residuals from VA medical care, finding that the proximate cause of the additional disability was not reasonably foreseeable.

The Veteran's death was not caused by a service-connected disability.,The Veteran did not meet the criteria for DIC under 38 U.S.C. § 1318.

The Board has remanded the cases due to insufficient information regarding the Veteran's exposure to herbicide agents during service. They need to determine if the U.S.S. Kitty Hawk was in additional areas as noted in the PACT Act, such as Thailand, Cambodia, Guam, American Samoa, and Johnston Atoll Island.

The Board has decided that the Veteran's cataracts are secondary to his diabetes mellitus and remands the case for further development.

The Veteran's claimed disabilities are not service-connected as they were not shown during or within one year after his military service, and there is no credible evidence of herbicide exposure in Vietnam.

The Veteran's claim for increased ratings for diabetes mellitus and earlier effective dates for diabetic neuropathy of the bilateral upper and lower extremities were denied. The rating for diabetes mellitus remains at 40 percent, with no change in effective date.

The Board has dismissed the claims for service connection of diabetes, bilateral feet disability, back disability, and allergic rhinitis due to the Veteran's death.

The Board denied service connection for diabetes and peripheral neuropathy of the bilateral upper and lower extremities, finding that there was no evidence of herbicide exposure in Korea and that the conditions were not related to service.